InfuSystem Holdings (INFU) Cash & Equivalents Growth (5y) (2015 - 2026)
InfuSystem Holdings (INFU) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.65 Bn | 148.00 Bn | 6.27 Bn |
| 2 | Stryker | 118.19 Bn | 115.31 Bn | 3.81 Bn |
| 3 | Medtronic | 103.03 Bn | 94.86 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.09 Bn | 70.88 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.78 Bn | 46.10 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | GE HealthCare Technologies | 29.11 Bn | 27.05 Bn | 1.98 Bn |
| 8 | Dexcom | 28.85 Bn | 27.73 Bn | 750.30 Mn |
| 9 | Steris | 20.38 Bn | 19.96 Bn | 697.10 Mn |
| 10 | InfuSystem Holdings | 180.28 Mn | 178.18 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27% |
| Dec 31, 2025 | -19.88% |
| Sep 30, 2025 | -13.21% |
| Jun 30, 2025 | 8.36% |
| Mar 31, 2025 | 37.63% |
| Dec 31, 2024 | -27.59% |
| Sep 30, 2024 | -34.52% |
| Jun 30, 2024 | -38.81% |
| Mar 31, 2024 | -15.43% |
| Dec 31, 2023 | -44.32% |
| Sep 30, 2023 | -47.09% |
| Jun 30, 2023 | -43.66% |
| Mar 31, 2023 | -30.06% |
| Dec 31, 2022 | -45.62% |
| Sep 30, 2022 | -14.68% |
| Jun 30, 2022 | 32.55% |
| Mar 31, 2022 | 15.86% |
| Dec 31, 2021 | -44.07% |
| Sep 30, 2021 | -31.22% |
| Jun 30, 2021 | -27.25% |